PRME vs. CRSP
Compare and contrast key facts about Prime Medicine Inc. Common Stock (PRME) and CRISPR Therapeutics AG (CRSP).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PRME or CRSP.
Performance
PRME vs. CRSP - Performance Comparison
Returns By Period
In the year-to-date period, PRME achieves a -64.11% return, which is significantly lower than CRSP's -24.44% return.
PRME
-64.11%
-27.40%
-57.77%
-51.82%
N/A
N/A
CRSP
-24.44%
-3.31%
-14.73%
-30.33%
-6.86%
N/A
Fundamentals
| PRME | CRSP | |
|---|---|---|
| Market Cap | $518.53M | $4.03B |
| EPS | -$2.17 | -$2.79 |
| Total Revenue (TTM) | $65.60M | $201.62M |
| Gross Profit (TTM) | $61.50M | $61.70M |
| EBITDA (TTM) | -$140.83M | -$287.95M |
Key characteristics
| PRME | CRSP | |
|---|---|---|
| Sharpe Ratio | -0.56 | -0.38 |
| Sortino Ratio | -0.49 | -0.24 |
| Omega Ratio | 0.95 | 0.97 |
| Calmar Ratio | -0.57 | -0.26 |
| Martin Ratio | -1.18 | -0.60 |
| Ulcer Index | 40.79% | 33.67% |
| Daily Std Dev | 86.13% | 51.67% |
| Max Drawdown | -84.94% | -81.61% |
| Current Drawdown | -84.94% | -77.48% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between PRME and CRSP is 0.48, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
PRME vs. CRSP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Prime Medicine Inc. Common Stock (PRME) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PRME vs. CRSP - Dividend Comparison
Neither PRME nor CRSP has paid dividends to shareholders.
Drawdowns
PRME vs. CRSP - Drawdown Comparison
The maximum PRME drawdown since its inception was -84.94%, roughly equal to the maximum CRSP drawdown of -81.61%. Use the drawdown chart below to compare losses from any high point for PRME and CRSP. For additional features, visit the drawdowns tool.
Volatility
PRME vs. CRSP - Volatility Comparison
Prime Medicine Inc. Common Stock (PRME) has a higher volatility of 23.39% compared to CRISPR Therapeutics AG (CRSP) at 17.94%. This indicates that PRME's price experiences larger fluctuations and is considered to be riskier than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PRME vs. CRSP - Financials Comparison
This section allows you to compare key financial metrics between Prime Medicine Inc. Common Stock and CRISPR Therapeutics AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities